Cue Biopharma reported revenue of $7.88M and net income of -$153.07M for the quarter ended Jun 2026. This income statement covers 37 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||||||
| Revenue | 2.74M | 2.40M | 8.25M | 1.00M | 0.03M | 0.07M | 0.15M | 0.19M | 1.38M | 2.10M | 1.82M | 1.72M | 2.66M | 3.34M | 1.58M | 0.42M | 2.95M | 2.15M | 9.50M | 7.88M | |||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 8.76M | 11.29M | 11.50M | 10.08M | 9.59M | 7.57M | 11.33M | 9.39M | 10.65M | 9.87M | 10.89M | 10.20M | 9.53M | 9.38M | 7.18M | 8.55M | 7.91M | 4.75M | 16.53M | 49.01M | |||||||||||||||||
| Selling, General & AdministrativeSG&A | 4.28M | 4.12M | 4.65M | 5.16M | 3.78M | 3.53M | 3.70M | 4.18M | 4.25M | 3.65M | 4.61M | 4.19M | 3.51M | 2.87M | 4.02M | 4.17M | 3.68M | 4.94M | 3.45M | 46.56M | |||||||||||||||||
| Other Operating ExpensesOther Opex | -0.26M | -0.02M | -0.16M | 0.10M | -0.00M | -0.05M | 0.02M | ||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 13.04M | 15.41M | 16.15M | 15.24M | 13.12M | 11.10M | 15.02M | 13.57M | 14.90M | 13.52M | 15.65M | 14.38M | 13.04M | 12.15M | 11.21M | 12.72M | 11.59M | 9.74M | 19.96M | 95.57M | |||||||||||||||||
| Operating IncomeOp. Inc | -10.30M | -13.02M | -7.89M | -14.24M | -13.09M | -11.03M | -14.87M | -13.38M | -13.52M | -11.42M | -13.83M | -12.67M | -10.38M | -8.81M | -9.63M | -12.30M | -8.63M | -7.59M | 1.98M | -87.69M | |||||||||||||||||
| EBIT | -10.30M | -13.02M | -7.89M | -14.24M | -13.09M | -11.03M | -14.87M | -13.38M | -13.52M | -11.42M | -13.83M | -12.67M | -10.38M | -8.81M | -9.63M | -12.30M | -8.63M | -7.59M | 1.98M | -87.69M | |||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.03M | 0.21M | 0.12M | ||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 0.03M | 0.00M | 0.01M | 0.09M | 0.20M | 0.63M | 0.64M | 0.56M | 0.70M | 0.91M | 0.56M | 0.43M | 0.34M | 0.29M | 0.17M | 0.20M | 0.22M | 0.16M | 0.16M | |||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | |||||||||||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.02M | 0.03M | 0.00M | -0.02M | -0.12M | 0.08M | 0.27M | 0.27M | 0.33M | 0.41M | 0.40M | 0.32M | 0.21M | 0.15M | 0.14M | 0.04M | 0.15M | 0.15M | 0.11M | -65.37M | |||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||
| EBT | -10.28M | -12.99M | -7.89M | -14.26M | -13.21M | -10.96M | -14.23M | -12.74M | -12.95M | -10.72M | -12.93M | -12.11M | -9.96M | -8.47M | -9.34M | -12.13M | -8.44M | -7.37M | 2.14M | -87.54M | |||||||||||||||||
| Tax ProvisionsTaxes | |||||||||||||||||||||||||||||||||||||
| Profit After TaxPAT | -10.28M | -12.99M | -8.38M | -14.26M | -13.21M | -11.05M | -14.60M | -13.11M | -13.19M | -11.01M | -13.43M | -12.35M | -10.17M | -8.66M | -9.50M | -12.26M | -8.48M | -7.45M | 1.58M | -153.07M | |||||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | 0.13M | 0.15M | |||||||||||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -10.28M | -12.99M | -7.89M | -14.26M | -13.21M | -10.96M | -14.23M | -12.74M | -12.95M | -10.72M | -12.93M | -12.11M | -9.96M | -8.47M | -9.34M | -12.13M | -8.44M | -7.37M | 2.14M | -87.54M | |||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -10.28M | -12.99M | -7.89M | -14.26M | -13.21M | -10.96M | -14.23M | -12.74M | -12.95M | -10.72M | -12.93M | -12.11M | -9.96M | -8.47M | -9.34M | -12.13M | -8.44M | -7.37M | 2.14M | -87.54M | |||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -10.28M | -12.99M | -7.89M | -14.26M | -13.21M | -10.96M | -14.23M | -12.74M | -12.95M | -10.72M | -12.93M | -12.11M | -9.96M | -8.47M | -9.34M | -12.13M | -8.44M | -7.37M | 2.14M | -87.54M | |||||||||||||||||
| Net Income towards Common StockholdersNet Income | -10.28M | -12.99M | -7.89M | -14.26M | -13.21M | -10.96M | -14.23M | -12.74M | -12.95M | -10.72M | -12.93M | -12.11M | -9.96M | -8.47M | -9.34M | -12.13M | -8.44M | -7.37M | 2.14M | -87.54M | |||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.33 | -0.41 | -0.25 | -0.44 | -0.37 | -0.31 | -0.40 | -0.29 | -0.29 | -0.23 | -0.28 | -0.24 | -0.20 | -0.17 | -0.17 | -0.16 | -0.09 | -0.07 | 0.02 | -13.81 | |||||||||||||||||
| EPS (Diluted) | -0.41 | -0.25 | -0.44 | -0.37 | -0.31 | -0.40 | -0.29 | -0.29 | -0.23 | -0.28 | -0.24 | -0.20 | -0.17 | -0.17 | -0.16 | -0.09 | -0.07 | 0.02 | -13.81 | ||||||||||||||||||
| Shares Outstanding | 31.23M | 31.52M | 31.29M | 32.64M | 35.36M | 35.38M | 35.65M | 44.65M | 44.80M | 46.36M | 45.75M | 49.47M | 50.17M | 51.23M | 56.33M | 74.25M | 95.46M | 100.87M | 94.73M | 6.34M | |||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 31.32M | 31.29M | 32.64M | 35.36M | 35.38M | 35.65M | 44.65M | 44.80M | 46.36M | 45.75M | 49.47M | 50.17M | 51.23M | 56.33M | 74.25M | 95.46M | 100.87M | 94.73M | 6.34M | ||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 31.47M | 31.36M | 32.20M | 34.17M | 35.38M | 35.39M | 35.65M | 43.18M | 43.74M | 45.12M | 47.22M | 48.64M | 48.64M | 60.21M | 61.82M | 61.82M | 76.45M | 100.87M | 96.62M | 5.23M | |||||||||||||||||
| EBITDA | -10.30M | -13.02M | -7.89M | -14.24M | -13.09M | -11.03M | -14.87M | -13.38M | -13.52M | -11.42M | -13.83M | -12.67M | -10.38M | -8.81M | -9.63M | -12.30M | -8.63M | -7.59M | 1.98M | -87.69M | |||||||||||||||||
| Interest ExpensesInt Expense | 0.03M | 0.21M | 0.12M | ||||||||||||||||||||||||||||||||||
| Tax Rate |